Moving on trial: COVID-19 and homelessness

COVID-19 and rough sleepers: a unique opportunity for a randomised controlled trial testing models of housing and support that reduce risks of infection and transmission, and reduce homelessness

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN69564614

Enrollment

150

Registered

2020-12-16

Start date

2021-01-06

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 and homelessness Other

Interventions

Current interventions as of 03/08/2021: This research will pursue a unique time limited opportunity to conduct a randomised controlled trial to evaluate the effectiveness and cost-effectiveness of p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Single person households temporarily accommodated by the local authority 2. Recourse to public funds

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Current primary outcome measure as of 03/08/2021: 1. Participant recruitment: Percentage of participants approached by LAs, and who are eligible, consent to the study (and thus are willing to be randomised) 2. LA recruitment: Number of LAs who entered study as a proportion of those approached and who showed some interest in the study. 3. Participant retention: Percentage of participants retained at final follow-up timepoint as a proportion of those recruited. 4. Adherence: LAs adhere to assignment of participant to randomised allocation. _____ Previous primary outcome measure: 1. Prevalence of COVID-19 infection at 12 months using self-report 2. Housing stability (number of days in settled accommodation and housing retention) at 12 months using self-report	—

Measure

Time frame

Current primary outcome measure as of 03/08/2021: 1. Participant recruitment: Percentage of participants approached by LAs, and who are eligible, consent to the study (and thus are willing to be randomised) 2. LA recruitment: Number of LAs who entered study as a proportion of those approached and who showed some interest in the study. 3. Participant retention: Percentage of participants retained at final follow-up timepoint as a proportion of those recruited. 4. Adherence: LAs adhere to assignment of participant to randomised allocation. _____ Previous primary outcome measure: 1. Prevalence of COVID-19 infection at 12 months using self-report 2. Housing stability (number of days in settled accommodation and housing retention) at 12 months using self-report

—

Secondary

Measure	Time frame
Current secondary outcome measures as of 03/08/2021: 1. Completeness of data collection at 3 and 6 months in relation to: 1.1. COVID-19 Infection 1.2. General health (EQ-5D) 1.3. Mental health (GAD-7, ONS-4) 1.4. Employment status 1.5. Income 1.6. Drug and alcohol (AUDIT C) use 1.7. Service access use for mental health 1.8. Drug and alcohol rehabilitation/ service use 1.9. Healthcare service use 1.10. Cost-effectiveness (including healthcare and mental health service use, and offending) 2. Data linkage: Percentage of participants consenting to data linkage _____ Previous secondary outcome measures: Assessed at baseline, 3, 6 and 12 -month follow-up: 1. General health measured using EQ-5D 2. Mental health measured using GAD-7, WEMWBS 3. Employment status measured using data linkage from DWP 5. Income measured using data linkage from DWP 6. Drug and alcohol (AUDIT C) use measured using NHS Digital 7. Service access use for mental health measured using NHS Digital 8. Drug and alcohol rehabilitation/ service use measured using NHS Digital 9. Healthcare service use measured using NHS Digital 10. Cost-effectiveness (including healthcare and mental health service use, and offending) measured using outline by Green Book (HM Treasury, 2018)	—

Measure

Time frame

Current secondary outcome measures as of 03/08/2021: 1. Completeness of data collection at 3 and 6 months in relation to: 1.1. COVID-19 Infection 1.2. General health (EQ-5D) 1.3. Mental health (GAD-7, ONS-4) 1.4. Employment status 1.5. Income 1.6. Drug and alcohol (AUDIT C) use 1.7. Service access use for mental health 1.8. Drug and alcohol rehabilitation/ service use 1.9. Healthcare service use 1.10. Cost-effectiveness (including healthcare and mental health service use, and offending) 2. Data linkage: Percentage of participants consenting to data linkage _____ Previous secondary outcome measures: Assessed at baseline, 3, 6 and 12 -month follow-up: 1. General health measured using EQ-5D 2. Mental health measured using GAD-7, WEMWBS 3. Employment status measured using data linkage from DWP 5. Income measured using data linkage from DWP 6. Drug and alcohol (AUDIT C) use measured using NHS Digital 7. Service access use for mental health measured using NHS Digital 8. Drug and alcohol rehabilitation/ service use measured using NHS Digital 9. Healthcare service use measured using NHS Digital 10. Cost-effectiveness (including healthcare and mental health service use, and offending) measured using outline by Green Book (HM Treasury, 2018)

—

Countries

United Kingdom, Wales

Contacts

Public ContactElizabeth Randell

randelle@cardiff.ac.uk+44 (0)292 0687608

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026